Bongiovanni et al. [60] also studied the expression of activation indicators and transmembrane receptors in platelets from hospitalized stable COVID-19 patients who did not have any pre-existing diseases and were not on any anticoagulants or antiplatelet drugs (except prophylactic low-molecular-weight heparin during hospitalization). Here, NRP1 is linked to COVID-19.